Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal rod cell | 8 studies | 53% ± 16% | |
retinal cone cell | 6 studies | 44% ± 20% | |
retinal ganglion cell | 5 studies | 44% ± 22% | |
GABAergic neuron | 5 studies | 40% ± 18% | |
neuron | 4 studies | 24% ± 6% | |
glutamatergic neuron | 4 studies | 54% ± 17% | |
interneuron | 4 studies | 34% ± 18% | |
ON-bipolar cell | 3 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 92% | 1469.67 | 2432 / 2642 | 99% | 13.59 | 698 / 705 |
skin | 99% | 4064.81 | 1797 / 1809 | 48% | 4.32 | 227 / 472 |
prostate | 56% | 203.80 | 136 / 245 | 87% | 8.16 | 439 / 502 |
esophagus | 54% | 527.54 | 786 / 1445 | 58% | 6.68 | 107 / 183 |
uterus | 44% | 149.08 | 75 / 170 | 64% | 7.57 | 293 / 459 |
tonsil | 0% | 0 | 0 / 0 | 89% | 8.13 | 40 / 45 |
adrenal gland | 3% | 12.55 | 8 / 258 | 86% | 18.45 | 197 / 230 |
bladder | 43% | 122.00 | 9 / 21 | 38% | 3.45 | 189 / 504 |
thymus | 8% | 25.21 | 54 / 653 | 66% | 24.04 | 399 / 605 |
blood vessel | 58% | 205.97 | 771 / 1335 | 0% | 0 | 0 / 0 |
ovary | 19% | 54.16 | 34 / 180 | 33% | 1.96 | 144 / 430 |
pancreas | 0% | 0 | 0 / 328 | 52% | 2.94 | 92 / 178 |
breast | 2% | 6.67 | 11 / 459 | 49% | 3.28 | 543 / 1118 |
intestine | 39% | 132.70 | 375 / 966 | 11% | 0.67 | 58 / 527 |
lung | 1% | 1.56 | 3 / 578 | 46% | 4.43 | 531 / 1155 |
kidney | 7% | 21.61 | 6 / 89 | 28% | 2.32 | 256 / 901 |
stomach | 15% | 53.25 | 54 / 359 | 13% | 0.76 | 37 / 286 |
lymph node | 0% | 0 | 0 / 0 | 28% | 1.15 | 8 / 29 |
eye | 0% | 0 | 0 / 0 | 5% | 1.84 | 4 / 80 |
liver | 0% | 0 | 0 / 226 | 5% | 0.35 | 19 / 406 |
adipose | 3% | 13.05 | 34 / 1204 | 0% | 0 | 0 / 0 |
heart | 2% | 5.54 | 16 / 861 | 0% | 0 | 0 / 0 |
spleen | 0% | 1.38 | 1 / 241 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.26 | 2 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 9.80 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0006633 | Biological process | fatty acid biosynthetic process |
GO_0042761 | Biological process | very long-chain fatty acid biosynthetic process |
GO_0034626 | Biological process | fatty acid elongation, polyunsaturated fatty acid |
GO_0019367 | Biological process | fatty acid elongation, saturated fatty acid |
GO_0006636 | Biological process | unsaturated fatty acid biosynthetic process |
GO_0009584 | Biological process | detection of visible light |
GO_0034625 | Biological process | fatty acid elongation, monounsaturated fatty acid |
GO_0035338 | Biological process | long-chain fatty-acyl-CoA biosynthetic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0008020 | Molecular function | G protein-coupled photoreceptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0009922 | Molecular function | fatty acid elongase activity |
Gene name | ELOVL4 |
Protein name | Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4) |
Synonyms | |
Description | FUNCTION: Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that catalyzes the synthesis of very long chain saturated (VLC-SFA) and polyunsaturated (PUFA) fatty acids that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May play a critical role in early brain and skin development. . |
Accessions | ENST00000369816.5 Q9GZR5 |